1. Global Health 50/50. The COVID-19 sex-disaggregated data tracker: England. https://globalhealth5050.org/the-sex-gender-and-covid-19-project/the-data-tracker/?explore=country&country=england#search.
2. The double edge sword of testosterone’s role in the COVID-19 pandemic;Younis;Front Endocrinol,2021
3. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532);Montopoli;Ann Oncol,2020
4. Dambha-Miller H, Hinton W, Joy M, Feher M, de Lusignan S. Mortality in COVID-19 amongst women on hormone replacement therapy or combined oral contraception: a cohort study. medRxiv preprint. https://doi.org/10.1101/2021.02.16.21251853.
5. Estetrol cotreatment of androgen deprivation therapy in infiltrating or metastatic, castration-sensitive prostate cancer: a randomized, double-blind, phase II trial (PCombi);Coelingh Bennink;Eur Urol Open Sci,2021